Premarket analyst action - healthcare Aug. 18, 2017
Opko Health (NYSEMKT:OPK) initiated with Overweight rating and $20 (240% upside) price target by Cantor Fitzgerald. Shares are up 3% premarket on average volume.
Heron Therapeutics (NASDAQ:HRTX) initiated with Overweight rating and $31 (103% upside) price target by Cantor Fitzgerald.
CymaBay Therapeutics (NASDAQ:CBAY) initiated with Buy rating and $15 (140% upside) price target by SunTrust. Shares are up 1% premarket.
WaVe Life Sciences (NASDAQ:WVE) initiated with Buy rating and $34 (104% upside) price target by Mizuho Securities.
Clovis Oncology (NASDAQ:CLVS) price target lowered to $107 (53% upside) from $115 by Leerink.
Tonix Pharmaceuticals (NASDAQ:TNXP) upgraded to Buy with a $6 (102% upside) price target by Roth Capital.
Myriad Genetics (NASDAQ:MYGN) upgraded to Hold by Deutsche Bank.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.